Up a level |
Papamargaritis, Dimitris ORCID: 0000-0001-5044-1515, Al-Najim, Werd, Lim, Jonathan ZM, Crane, James, Bodicoat, Danielle H, Barber, Shaun, Lean, Michael, McGowan, Barbara, O’Shea, Donal, Webb, David R et al (show 3 more authors)
(2024)
Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial.
The Lancet Regional Health - Europe, 39.
p. 100853.
Sargeant, Jack A, King, James A, Yates, Thomas, Redman, Emma L, Bodicoat, Danielle H, Chatterjee, Sudesna, Edwardson, Charlotte L, Gray, Laura J, Poulin, Benoit, Waheed, Ghazala et al (show 7 more authors)
(2022)
The effects of empagliflozin, dietary energy restriction, or both on appetite-regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double-blind, placebo-controlled trial.
DIABETES OBESITY & METABOLISM, 24 (8).
pp. 1509-1521.